![]() To optimize the treatment and recovery of patients with the limited medical resources, it is of great significance to identify early detection prognostic biomarkers to discriminate COVID-19 patients who would probably develop critical illness and to evaluate their relevant mortality risk during the global pandemic. The death risk induced by severity of COVID-19 posed great pressure on medical service, resulting in a shortage of critical care resources and heavy disease burden. ![]() The largest present report conducted by the Chinese Centre for Disease Control and Prevention with 72,314 cases revealed the average case-fatality rate was 2.3%, while a retrospective study among 379 critically ill adult patients have observed a striking day-28 mortality of 27%, ascending sharply with older age and for patients with latent comorbidities. and European countries, the most affected regions with increasing mortality, jointly account for over 47% of cases and 44% of deaths in the world. Till 15 November 2020, the outbreak of COVID-19 had caused more than 53 million individuals infected and more than 1.3 million people dead globally specifically, the U.S. The continuous pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory coronavirus 2 (SARS-CoV-2) is showing an unprecedented attack to the global health system.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |